ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,873Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 3593

$1.47M Total Retail Price of All Prescriptions

Rank: 53 out of 3593

842 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 842 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 842 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 26,923 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,454 1,372 1 1
LEVOTHYROXINE SODIUM 1,103 1,065 2 4
HYDROCODONE-ACETAMINOPHEN 981 907 S3 3 7
LISINOPRIL 870 821 4 2
FUROSEMIDE 864 844 5 9
OMEPRAZOLE 820 764 6 5
WARFARIN SODIUM 760 751 7 18
METOPROLOL TARTRATE 699 658 8 8
ZOLPIDEM TARTRATE 644 593 9 12
AMLODIPINE BESYLATE 572 548 10 3
HYDROCHLOROTHIAZIDE 544 503 11 10
MELOXICAM 529 493 12 29
SERTRALINE HCL 489 461 13 28
GABAPENTIN 454 436 14 16
TAMSULOSIN HCL 447 418 15 33
DONEPEZIL HCL 444 410 16 31
POTASSIUM CHLORIDE 370 350 17 24
METFORMIN HCL 347 318 18 6
LOVASTATIN 290 289 19 20
CITALOPRAM HBR 256 243 20 25
CARVEDILOL 255 240 21 23
METOLAZONE 241 235 22 254
ALENDRONATE SODIUM 238 238 23 22
ADVAIR DISKUS 236 229 24 47
DIGOXIN 225 225 25 58
ATENOLOL 216 206 26 11
FENTANYL 216 202 S2 26 137
FLUTICASONE PROPIONATE 201 187 28 32
ALLOPURINOL 197 197 29 35
NAMENDA 185 162 30 50
SPIRIVA 184 184 31 87
CLOPIDOGREL 183 163 32 30
POLYETHYLENE GLYCOL 3350 182 181 33 143
ATORVASTATIN CALCIUM 172 169 34 15
PREDNISONE 172 163 34 49
FINASTERIDE 166 166 36 79
TRAMADOL HCL 163 139 37 17
MIRTAZAPINE 158 145 38 64
ISOSORBIDE MONONITRATE ER 155 152 39 61
AZITHROMYCIN 151 144 40 34
FENOFIBRATE 148 147 41 39
METOPROLOL SUCCINATE 143 133 42 19
GLIPIZIDE 142 138 43 40
FLUOXETINE HCL 141 104 44 60
PLAVIX 140 128 45 42
SPIRONOLACTONE 139 137 46 86
NITROFURANTOIN MONO-MACRO 137 136 47 242
TERAZOSIN HCL 137 137 47 115
CIPROFLOXACIN HCL 136 126 49 52
NEXIUM 136 109 49 36
PAROXETINE HCL 136 135 49 62
LOSARTAN POTASSIUM 132 128 52 14
PRAVASTATIN SODIUM 128 116 53 13
LYRICA 128 107 53 105
JANUVIA 125 125 55 81
OXYBUTYNIN CHLORIDE 125 122 55 104
LEVEMIR 125 113 55 193
DIOVAN 121 120 58 46
CARBIDOPA-LEVODOPA 117 106 59 135
NOVOLOG 116 116 60 134
CYMBALTA 115 97 61 73
SULFAMETHOXAZOLE-TRIMETHOPRIM 108 104 62 102
OXYCODONE-ACETAMINOPHEN 108 107 S2 62 93
RANITIDINE HCL 106 104 64 27
CLOTRIMAZOLE-BETAMETHASONE 104 100 65 94
PROAIR HFA 101 84 66 54
HYDRALAZINE HCL 99 88 67 107
CEPHALEXIN 96 88 68 150
RAMIPRIL 95 88 69 92
QUETIAPINE FUMARATE 93 84 70 89
PROMETHAZINE HCL 92 55 R 71 142
LANTUS 92 86 71 57
SYNTHROID 90 78 73 51
DIOVAN HCT 87 73 74 76
OXYBUTYNIN CHLORIDE ER 86 86 75 175
ROPINIROLE HCL 84 82 76 144
CELEBREX 81 77 77 100
PRIMIDONE 81 71 77 282
EVISTA 77 77 79 200
VERAPAMIL ER 76 76 80 99
NYSTOP 74 53 81 309
ENALAPRIL MALEATE 74 74 81 38
CRESTOR 74 66 81 21
MECLIZINE HCL 73 66 84 96
SODIUM CHLORIDE 73 47 84 344
CYCLOBENZAPRINE HCL 71 50 R 86 72
GEMFIBROZIL 70 67 87 88
ALBUTEROL SULFATE 70 69 87 157
DIVALPROEX SODIUM 68 68 89 121
METHOCARBAMOL 65 54 R 90 185
IPRATROPIUM-ALBUTEROL 65 65 90 154
LIDODERM 65 62 90 78
CLONIDINE HCL 64 64 93 41
PENTOXIFYLLINE 64 64 93 149
GLIMEPIRIDE 63 63 95 44
FAMOTIDINE 62 62 96 70
DILTIAZEM 24HR CD 62 62 96 173
VENLAFAXINE HCL ER 61 61 98 178
AMITRIPTYLINE HCL 61 59 R 98 90
ACTOS 60 59 100 133
LEVOFLOXACIN 58 57 101 116
ZETIA 58 46 101 110
PROPRANOLOL HCL 58 53 101 181
SUCRALFATE 56 56 104 237
NYSTATIN 55 49 105 167
GLYBURIDE 55 54 R 105 55
LATANOPROST 55 55 105 195
COMBIVENT 54 38 108 161
ABILIFY 54 34 108 162
FLUCONAZOLE 54 41 108 229
MEGESTROL ACETATE 53 53 R 111 152
GLIPIZIDE XL 53 53 111 179
HYDROXYZINE HCL 52 51 R 113 196
NOVOLIN R 52 50 113 140
TRICOR 51 50 115 130
RISPERIDONE 51 47 115 83
TRIAMCINOLONE ACETONIDE 50 50 117 119
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 18, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.